Atlas Trials

A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

Clinical trial NCT07305779 · COMPLETED

Trial details

NCT number
NCT07305779
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2025-03-07
Primary completion
2025-05-03
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.